SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

06 Feb 2024 Evaluate
A slight decline in the revenue of Rs. 1667.60 millions was seen for the December 2023 quarter as against Rs. 1689.56 millions during year-ago period.The Net Profit of the company registered a slight decline of -14.44% to Rs. 321.09  millions from Rs. 375.30 millions.Operating profit for the quarter ended December 2023 rose to 613.36 millions as compared to 582.40 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202312 202212 % Var
Sales 1667.60 1689.56 -1.30 1667.60 1689.56 -1.30 1667.60 1689.56 -1.30
Other Income 67.54 64.95 3.99 67.54 64.95 3.99 67.54 64.95 3.99
PBIDT 613.36 582.40 5.32 613.36 582.40 5.32 613.36 582.40 5.32
Interest 0.37 3.54 -89.55 0.37 3.54 -89.55 0.37 3.54 -89.55
PBDT 515.56 578.86 -10.94 515.56 578.86 -10.94 515.56 578.86 -10.94
Depreciation 78.55 66.77 17.64 78.55 66.77 17.64 78.55 66.77 17.64
PBT 437.01 512.09 -14.66 437.01 512.09 -14.66 437.01 512.09 -14.66
TAX 115.92 136.79 -15.26 115.92 136.79 -15.26 115.92 136.79 -15.26
Deferred Tax -10.08 -4.29 134.97 -10.08 -4.29 134.97 -10.08 -4.29 134.97
PAT 321.09 375.30 -14.44 321.09 375.30 -14.44 321.09 375.30 -14.44
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 36.78 34.47 6.70 36.78 34.47 6.70 36.78 34.47 6.70

Blue Jet Healthcare Share Price

409.75 2.00 (0.49%)
16-Apr-2026 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.45
Dr. Reddys Lab 1219.20
Cipla 1229.70
Zydus Lifesciences 939.65
Lupin 2317.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×